Announcement by Wajd Life Trading Company on the Board of Directors' Approval to Activate the General Medical Complex Activity
| Element List | Explanation |
|---|---|
| Announcement Detail | Wajd Life Trading Company announces that its Board of Directors, on 15 October 2026, resolved to approve the activation of the general medical complex activity, which is included among the Company's objectives in its Articles of Association and commercial register. This comes as part of the Company's strategy to diversify its sources of income and leverage its experience and capabilities in the healthcare sector. The Company clarifies that the current phase includes completing and updating the feasibility study for investing in the activity, and evaluating the available investment and operational alternatives in order to select the most suitable one. The location of the complex, the method of implementation, the final investment costs, the financing requirements, and the operational timeline have not yet been determined. These aspects will be determined in light of the results of the studies, the evaluation of alternatives, and the completion of the required approvals. Expected Financial Impact: It is not currently possible to determine the expected financial impact or the period in which it will be reflected in the Company's financial statements, as the evaluation of alternatives, the selection of the investment alternative, and the determination of its costs and its operational and financing requirements have not been completed. Additional Information: The practice of the activity is subject to completing the required regulatory requirements and procedures and obtaining the necessary licenses from the competent authorities. The Company will announce any material developments in this regard in due course, in accordance with the relevant regulations and instructions |
Comments